Table 4.

The proportion (%) of patients who received each blood product and factor concentrate across all examined periods

	Study group	Control group	p value
RBC [number of patients (%)] Operating room 1 st day of ICU stay 2nd day of ICU stay	36 (97.3%) 17 (42.5%) 14 (35.0%)	35 (97.2%) 27 (71.1%) 26 (68.4%)	0.98 0.01 0.003
FFP [number of patients (%)] Operating room 1 st day of ICU stay 2nd day of ICU stay	18 (48.6%) 12 (30.0%) 3 (7.5%)	27 (75.0%) 23 (60.5%) 11 (28.9%)	0.02 0.006 0.01
PLT [number of patients (%)] Operating room 1 st day of ICU stay 2nd day of ICU stay	3 (8.1%) 4 (10.0%) 2 (5.0%)	4 (11.1%) 7 (18.4%) 3 (7.9%)	0.96 0.45 0.95
Cryoprecipitate [number of patients (%)] Operating room 1 st day of ICU stay 2nd day of ICU stay	4 (10.8%) 5 (12.5%) 1 (2.5%)	2 (5.6%) 0 (0.0%) 0 (0.0%)	0.69 0.07 0.32
FC [number of patients (%)] Operating room 1 st day of ICU stay 2nd day of ICU stay	7 (18.9%) 8 (20.0%) 1 (2.5%)	5 (13.9%) 5 (13.2%) 0 (0.0%)	0.79 0.81 0.32
PCC [number of patients (%)] Operating room 1 st day of ICU stay 2nd day of ICU stay	0 (0.0%) 1 (2.5%) 1 (2.5%)	3 (8.3%) 5 (13.2%) 0 (0.0%)	0.22 0.18 0.32
Tranexamic acid [number of patients (%)] Operating room 1 st day of ICU stay 2nd day of ICU stay	20 (55.5%) 8 (20.0%) 0 (0.0%)	8 (22.8%) 4 (10.5%) 0 (0.0%)	0.01 0.39 –

RBC red blood cells, FFP fresh frozen plasma, PLT platelets, FC fibrinogen concentrate, PCC prothrombin complex concentrate